TSMC at $394: Is This a Buy, Sell, or Hold Strategy?
Taiwan Semiconductor sits near $394 as Q1 2026 beat and AI demand boost growth; investors ponder whether to buy, sell...
When To Revise Your Retirement Strategy
Knowing when to revise your retirement strategy is key to staying on track. Learn the indicators that signal it's time for an adjustment.
20,855 articlesStifel Just Crowned CrowdStrike: Bulls See Lifted Target
Stifel boosted CrowdStrike’s target to $660 ahead of the June earnings release, signaling renewed optimism on growth ...
Vice President Vance Rebuts Trump Stock Claims Amid Scrutiny
Vice President JD Vance publicly pushed back on questions about President Trump's stock trading, arguing that the bil...
Will Stock Reach $600? AMD Eyes a New AI Era in 2026
Investors are weighing whether AMD can reach $600 this year as AI-driven demand and enterprise partnerships could lif...
SpaceX IPO Filing Gives Crypto Investors New Price Tool
SpaceX's S-1 filing exposes Bitcoin exposure and a broader digital-asset playbook, signaling a new price benchmark fo...
Regulations Expand, States Debate HEI Classification
States are racing to regulate home equity investment products as the market grows, with Maine enacting strict licensi...
Bitcoin’s Trade Flips Bond as Fed Outlook Shifts Markets
Bitcoin’s trade flips bond as the bond market takes control of financial conditions, signaling a pivot from easy-mone...
Kevin Warsh Trial to Tighten Policy Without Trump Backlash
As inflation persists, investors consider whether kevin warsh tighten policy through balance-sheet tools can curb pri...
Spotify Aiming Billion Users: Path to 2030 Margin Goals
Spotify unveiled a long-term plan to hit 1 billion active users and sustain 20% operating margins by 2030, highlighti...
Best Stocks Right Now: Energy Stocks Lead Market Rally
Energy stocks are rallying as market volatility persists, highlighting the best stocks right now for investors seekin...
NIO Today Outperforming Other Stocks in EV Rally Momentum
NIO shares jumped about 9% following the ES9 launch, with rivals like Tesla and Rivian moving in the same market rall...
Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Time To Notice Score Change After Secured Card
Secured Card Reported To Credit Bureaus Instantly